A Randomised Phase-III Study Comparing Cytoreductive Surgery Plus Intraperitoneal Chemotherapy Versus Modern Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis.
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Overall survival
8 years
No
Wilhelm Graf, M.D. Ph.D
Principal Investigator
Uppsala University
Sweden: Swedish National Council on Medical Ethics
SPS-1
NCT01524094
June 2003
January 2012
Name | Location |
---|